IPO - SHOULDER INNOVATIONS, INC.

Form Type: S-1

Filing Date: 2025-07-07

Corporate Action: Ipo

Type: New

Accession Number: 000162828025034437

Filing Summary: Shoulder Innovations, Inc. has filed an S-1 registration statement with the SEC for an initial public offering of shares of common stock. The company is focused on transforming shoulder surgical care and offers advanced implant systems for shoulder arthroplasty. The registration outlines that there has been no public market for its common stock prior to this offering. The company anticipates an offering price that is yet to be determined and has applied to list its common stock on the NYSE under the symbol 'SI'. As an emerging growth and smaller reporting company, it will comply with reduced public company reporting requirements. It highlights significant growth potential in shoulder arthroplasty, with approximately 250,000 procedures expected in the U.S. in 2025, corresponding to a market opportunity of around $1.7 billion. The filing also details the company's financial performance, noting a revenue increase from $19.3 million in 2023 to $31.6 million in 2024, along with ongoing clinical validations of its products and a robust product pipeline aimed at addressing unmet clinical needs.

Form Type: DRS/A

Filing Date: 2025-06-18

Corporate Action: Ipo

Type: New

Accession Number: 000162828025032169

Filing Summary: Shoulder Innovations, Inc. is conducting an initial public offering (IPO) of common stock as detailed in their confidential filing with the SEC, submitted as Amendment No. 2 to a draft registration statement. The company focuses exclusively on shoulder surgical care, aiming to revolutionize the market with advanced implant systems for shoulder arthroplasty. Although prior to this offering, there was no public market for their common stock, they anticipate an initial offering price between $ and $ per share. The offering will also seek approval for listing on the NYSE under the symbol 'SI'. The document outlines the technological advancements and business strategies that support their position as a leader in the shoulder surgical care market. Major risks associated with investing in their stock are acknowledged, including the potential underutilization of surgical treatments and market volatility. The company is classified as an 'emerging growth company' and has significant growth projections within the shoulder surgical care market, estimated to be worth $1.7 billion in the U.S. alone for shoulder arthroplasty procedures in 2025, with growth anticipated at approximately 11% annually through 2029, reaching a global market opportunity of around $2.8 billion.

Form Type: DRS/A

Filing Date: 2025-05-23

Corporate Action: Ipo

Type: New

Accession Number: 000162828025027560

Filing Summary: Shoulder Innovations, Inc. has filed Amendment No. 1 to its draft registration statement on May 23, 2025, pertaining to its initial public offering (IPO) of common stock. The company aims to offer shares of its common stock, with the initial public offering price expected to range between a specified low and high per share. This document indicates that prior to the offering, there was no public market for the company's common stock, and the company intends to list its stock under the trading symbol 'SHOU' once it receives the necessary approvals. Being classified as an 'emerging growth company' and a 'smaller reporting company,' Shoulder Innovations will comply with reduced public company reporting requirements. The offering is aimed at raising funds to support its business strategy focusing on the rapidly growing shoulder surgical care market, particularly through the development of advanced implant systems and technologies. The prospectus analyzes the market conditions for the treatment of shoulder pain and outlines the company's innovative solutions designed to address existing clinical challenges and enhance surgical outcomes, ultimately supporting its strategies to capture a significant share in a projected $3.4 billion global shoulder arthroplasty market by 2025. As the company prepares for the IPO, it highlights its potential growth driven by advancements in shoulder surgical care, emphasizing the utilization of its proprietary technologies such as the ProVoyance preoperative planning tool and a unique instrument tray system.

Form Type: DRS

Filing Date: 2025-04-17

Corporate Action: Ipo

Type: New

Accession Number: 000162827925000227

Filing Summary: Shoulder Innovations, Inc. is filing a draft registration statement for an initial public offering (IPO) of shares of common stock. The company is focused on transforming the shoulder surgical care market by offering advanced implant systems for shoulder arthroplasty. Their business model emphasizes procedural efficiency and improved outcomes through an ecosystem that includes preoperative planning technologies and specialized support. The offering is contingent upon obtaining approval to list their common stock on the Nasdaq Global Market under the symbol 'SHOU.' The approximate date for the commencement of the proposed sale is as soon as practicable after the effective date of the registration statement. Notably, there has been significant revenue growth from sales of advanced implant systems, with major revenue increases year-over-year, indicating a strong market opportunity in the shoulder surgical care sector, which is estimated to be a $3.4 billion market globally for shoulder arthroplasty. The document outlines the risks associated with the business, bolstering the case for investor scrutiny prior to any investment decisions.